A comprehensive view of Infections & Infectious Diseases. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Pulp & Paper Industry Market Intelligence Service.
GSK reports positive data on co-administration of AREXVY and SHINGRIX vaccines; trial meets primary endpoint with non-inferior immune response and acceptable safety profiles for both vaccines
Published:
September 18, 2024
by GSK Group (GlaxoSmithKline)
|
AHA reports physician burnout rates fall below 50%; Association launches campaign to recognize EVS technicians' role in infection prevention
Published:
September 18, 2024
by Industry Intelligence Inc.
|
Betco Corp. promotes disinfectants effective against Mpox; company to unveil innovations at ISSA Show North America and BSCAI Contracting Success Conference in Las Vegas this November
Published:
September 18, 2024
by Industry Intelligence Inc.
|
Abbott Laboratories surveys 100+ infectious disease experts on pandemic preparedness; experts highlight disease surveillance gaps, public health funding, climate change impact on outbreaks
Published:
September 18, 2024
by Industry Intelligence Inc.
|
US Patent Issued to Regeneron Pharmaceuticals on Sept. 17 for "Anti-PfRH5 antibodies and antigen-binding fragments thereof" (New York Inventor)
Published:
September 18, 2024
by U.S. Fed News
|
Ask us about our Pulp & Paper Industry market view